申请人:Beswick Paul
公开号:US20130210796A1
公开(公告)日:2013-08-15
The present invention relates to novel tetrazole compounds; to processes for their preparation; to pharmaceutical compositions containing the compounds; and to the use of the compounds in therapy to treat diseases for which blocking the Ca
v
2.2 calcium channels is beneficial. Formula (I) wherein A is: (II) or (III)
wherein
A is
本发明涉及新型四唑化合物;它们的制备过程;包含这些化合物的制药组合物;以及使用这些化合物治疗阻断Cav2.2钙通道对疾病有益的疗法。式(I)其中A为:(II)或(III)其中A为